NCT04498156View on ClinicalTrials.gov

Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Renal Insufficiency, Chronic
Interventions
OTHER

No intervention

No intervention, observational study

Trial Locations (1)

Unknown

Many Facilities, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

LMC Diabetes & Endocrinology

UNKNOWN

lead

Bayer

INDUSTRY

NCT04498156 - Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D) | Biotech Hunter | Biotech Hunter